These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5. Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151 [TBL] [Abstract][Full Text] [Related]
6. Location and Cell-Type-Specific Bias of Metabotropic Glutamate Receptor, mGlu Jong YI; Harmon SK; O'Malley KL ACS Chem Neurosci; 2019 Nov; 10(11):4558-4570. PubMed ID: 31609579 [TBL] [Abstract][Full Text] [Related]
7. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377 [TBL] [Abstract][Full Text] [Related]
8. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology. Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654 [TBL] [Abstract][Full Text] [Related]
9. Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5. Arsova A; Møller TC; Vedel L; Hansen JL; Foster SR; Gregory KJ; Bräuner-Osborne H Mol Pharmacol; 2020 Jul; 98(1):49-60. PubMed ID: 32358164 [TBL] [Abstract][Full Text] [Related]
10. Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition. Ellard JM; Madin A; Philps O; Hopkin M; Henderson S; Birch L; O'Connor D; Arai T; Takase K; Morgan L; Reynolds D; Talma S; Howley E; Powney B; Payne AH; Hall A; Gartlon JE; Dawson LA; Castro L; Atkinson PJ Bioorg Med Chem Lett; 2015 Dec; 25(24):5792-6. PubMed ID: 26531152 [TBL] [Abstract][Full Text] [Related]
11. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery. Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634 [TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators. Bennett KA; Christopher JA; Tehan BG Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871 [TBL] [Abstract][Full Text] [Related]
13. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators. Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210 [TBL] [Abstract][Full Text] [Related]